Unjha Formul.

Market Cap: Micro Cap
Industry: Pharmaceuticals & Biotechnology
ISIN: INE576D01015
NSEID:
BSEID: 531762
View on BSE

INR

30.50

-1.5 (-4.69%)

BSENSE

Sep 24, 03:30 PM

BSE+NSE Vol: 1.88 k

{
  "main_header": {
    "sid": 782664,
    "name": "Unjha Formul.",
    "stock_name": "Unjha Formul.",
    "full_name": "Unjha Formulations Ltd",
    "name_url": "stocks-analysis/unjha-formul",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 0,
    "country_id": 34,
    "currency": "INR",
    "cmp": "30.50",
    "chg": -1.5,
    "chgp": "-4.69%",
    "dir": -1,
    "prev_price": "32.00",
    "mcapval": "14.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 531762,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE576D01015",
    "curr_date": "Sep 24, 03:30 PM",
    "curr_time": "03:56 AM",
    "last_traded_at": "Sep 24, 03:30 PM IST",
    "bse_nse_vol": "1.88 k",
    "exc_status": "Active",
    "traded_date": "Sep 24, 2026",
    "traded_date_str": "2026 09 24",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/unjha-formul-782664-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Broad-Based Technical Strength Lifts Unjha Formulations Ltd to 52-Week High of Rs 36.38",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/unjha-formulations-ltd-hits-new-52-week-high-at-rs3638-4189458",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/UnjhaFormulatio_priceRelatedfactors_4189458.png",
        "date": "2026-09-10 11:41:07",
        "description": "Surging past its previous peak, Unjha Formulations Ltd reached a fresh 52-week high of Rs 36.38 on 10 Sep 2026, propelled by a sustained rally that has delivered a 46.16% gain over the past ten trading sessions."
      },
      {
        "title": "Broad-Based Technical Strength Lifts Unjha Formulations Ltd to 52-Week High of Rs 35.39",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/unjha-formulations-ltd-hits-new-52-week-high-at-rs3539-4188110",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/UnjhaFormulatio_priceRelatedfactors_4188110.png",
        "date": "2026-09-09 10:43:54",
        "description": "After a sustained rally over the past nine sessions, Unjha Formulations Ltd surged to a fresh 52-week high of Rs 35.39 on 9 Sep 2026, marking a 42.19% gain since its recent low. This price milestone is underpinned by a confluence of bullish technical indicators and robust price momentum, setting the stock apart in a market environment where the broader Sensex has been under pressure."
      },
      {
        "title": "Broad-Based Technical Strength Lifts Unjha Formulations Ltd to 52-Week High of Rs 33.4",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/unjha-formulations-ltd-hits-new-52-week-high-at-rs334-4186659",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/UnjhaFormulatio_priceRelatedfactors_4186659.png",
        "date": "2026-09-08 10:36:51",
        "description": "With a decisive surge to Rs 33.4 on 8 Sep 2026, Unjha Formulations Ltd has reached a fresh 52-week high, marking a 91% rally from its low of Rs 17.52 over the past year. This milestone is underscored by a strong alignment of technical indicators and sustained price momentum, even as the broader market struggles to hold ground."
      },
      {
        "title": "Broad-Based Technical Strength Lifts Unjha Formulations Ltd to 52-Week High of Rs 32",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/unjha-formulations-ltd-hits-new-52-week-high-at-rs-32-4184971",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/UnjhaFormulatio_priceRelatedfactors_4184971.png",
        "date": "2026-09-07 10:36:20",
        "description": "Surging to a fresh 52-week high of Rs 32 on 7 Sep 2026, Unjha Formulations Ltd has demonstrated remarkable price momentum, outperforming its sector and the broader market despite a subdued Sensex environment."
      },
      {
        "title": "Unjha Formulations Gains 17.30%: 4 Key Factors Driving the Surge",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/unjha-formulations-gains-1730-4-key-factors-driving-the-surge-4183676",
        "imagepath": "",
        "date": "2026-09-05 15:07:24",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>31 Aug:</strong> Upgraded to Hold on Technical and Valuation Improvements</p>\n                    <p><strong>1 Sep:</strong> Downgraded to Sell amid Mixed Technicals and Fair Valuation</p>\n                    <p><strong>1 Sep:</strong> Valuation Shift Signals Caution Amid Strong Returns</p>\n                    <p><strong>4 Sep:</strong> Hits New 52-Week High at Rs.30.5</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.26.12</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.30.64</div><..."
      },
      {
        "title": "Broad-Based Technical Strength Lifts Unjha Formulations Ltd to 52-Week High of Rs 30.5",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/unjha-formulations-ltd-hits-new-52-week-high-at-rs305-4182604",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/UnjhaFormulatio_priceRelatedfactors_4182604.png",
        "date": "2026-09-04 10:44:00",
        "description": "Surging to a fresh 52-week high of Rs 30.5 on 4 Sep 2026, Unjha Formulations Ltd has demonstrated remarkable price momentum, outperforming its sector and the broader market over the past week and beyond."
      },
      {
        "title": "Unjha Formulations Ltd Downgraded to Sell Amid Mixed Technicals and Fair Valuation",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/unjha-formulations-ltd-downgraded-to-sell-amid-mixed-technicals-and-fair-valuation-4177054",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/UnjhaFormulatio_mojoScore_4177054.png",
        "date": "2026-09-01 08:14:45",
        "description": "Unjha Formulations Ltd has seen its investment rating downgraded from Hold to Sell, reflecting a reassessment across key parameters including technical trends, valuation metrics, financial performance, and overall quality. Despite recent price gains and market-beating returns, the company’s micro-cap status and flat quarterly results have weighed on its outlook, prompting a cautious stance from analysts."
      },
      {
        "title": "Unjha Formulations Ltd: Valuation Shift Signals Caution Amid Strong Returns",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/unjha-formulations-ltd-valuation-shift-signals-caution-amid-strong-returns-4176621",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/UnjhaFormulatio_valuationdot_4176621.png",
        "date": "2026-09-01 08:00:41",
        "description": "Unjha Formulations Ltd has experienced a notable shift in its valuation parameters, moving from an attractive to a fair valuation grade amid evolving market dynamics. This change reflects a recalibration of investor sentiment, driven by adjustments in key metrics such as the price-to-earnings (P/E) and price-to-book value (P/BV) ratios, when compared to both historical levels and peer benchmarks within the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Unjha Formulations Ltd Upgraded to Hold on Technical and Valuation Improvements",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/unjha-formulations-ltd-upgraded-to-hold-on-technical-and-valuation-improvements-4175454",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/UnjhaFormulatio_mojoScore_4175454.png",
        "date": "2026-08-31 08:03:21",
        "description": "Unjha Formulations Ltd has seen its investment rating upgraded from Sell to Hold, reflecting a notable improvement in its technical indicators and valuation metrics despite flat recent financial performance. The upgrade, effective from 28 August 2026, is driven primarily by bullish technical trends, attractive valuation relative to peers, and a stable financial outlook, positioning the micro-cap pharmaceutical company for cautious optimism among investors."
      }
    ],
    "total": 167,
    "sid": "782664",
    "stock_news_url": "https://www.marketsmojo.com/news/unjha-formulations-782664"
  },
  "announcements": [
    {
      "caption": "Submissions Of XML File For Financial Statement I.E. Balance Sheet P&L Accounts And Cash Flow Statement As On 31.03.2026 (AGM Held On 14/08/2026) As Per SEBI (Listing Obligation And Disclosure Requirements) Regulations2015",
      "datetime": "08-Sep-2026",
      "details": "Submission of XML file for Financial Statement as on 31/03/2026",
      "source": "BSE"
    },
    {
      "caption": "Submissions Of XML File For Financial Statement I.E. Balance Sheet P&L Accounts And Cash Flow Statement As On 31.03.2026 (AGM Held On 14/08/2026) As Per SEBI (Listing Obligation And Disclosure Requirements) Regulations2015",
      "datetime": "08-Sep-2026",
      "details": "Submission of XML file for Financial Statement as on 31/03/2026",
      "source": "BSE"
    },
    {
      "caption": "Filing Of Distribution Schedule",
      "datetime": "14-Aug-2026",
      "details": "As per Regulation of SEBI(LODR) Regulation2015",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Broad-Based Technical Strength Lifts Unjha Formulations Ltd to 52-Week High of Rs 36.38

2026-09-10 11:41:07

Surging past its previous peak, Unjha Formulations Ltd reached a fresh 52-week high of Rs 36.38 on 10 Sep 2026, propelled by a sustained rally that has delivered a 46.16% gain over the past ten trading sessions.

Read full news article

Broad-Based Technical Strength Lifts Unjha Formulations Ltd to 52-Week High of Rs 35.39

2026-09-09 10:43:54

After a sustained rally over the past nine sessions, Unjha Formulations Ltd surged to a fresh 52-week high of Rs 35.39 on 9 Sep 2026, marking a 42.19% gain since its recent low. This price milestone is underpinned by a confluence of bullish technical indicators and robust price momentum, setting the stock apart in a market environment where the broader Sensex has been under pressure.

Read full news article

Broad-Based Technical Strength Lifts Unjha Formulations Ltd to 52-Week High of Rs 33.4

2026-09-08 10:36:51

With a decisive surge to Rs 33.4 on 8 Sep 2026, Unjha Formulations Ltd has reached a fresh 52-week high, marking a 91% rally from its low of Rs 17.52 over the past year. This milestone is underscored by a strong alignment of technical indicators and sustained price momentum, even as the broader market struggles to hold ground.

Read full news article

Broad-Based Technical Strength Lifts Unjha Formulations Ltd to 52-Week High of Rs 32

2026-09-07 10:36:20

Surging to a fresh 52-week high of Rs 32 on 7 Sep 2026, Unjha Formulations Ltd has demonstrated remarkable price momentum, outperforming its sector and the broader market despite a subdued Sensex environment.

Read full news article

Unjha Formulations Gains 17.30%: 4 Key Factors Driving the Surge

2026-09-05 15:07:24

Key Events This Week

31 Aug: Upgraded to Hold on Technical and Valuation Improvements

1 Sep: Downgraded to Sell amid Mixed Technicals and Fair Valuation

1 Sep: Valuation Shift Signals Caution Amid Strong Returns

4 Sep: Hits New 52-Week High at Rs.30.5

Read full news article

Broad-Based Technical Strength Lifts Unjha Formulations Ltd to 52-Week High of Rs 30.5

2026-09-04 10:44:00

Surging to a fresh 52-week high of Rs 30.5 on 4 Sep 2026, Unjha Formulations Ltd has demonstrated remarkable price momentum, outperforming its sector and the broader market over the past week and beyond.

Read full news article

Unjha Formulations Ltd Downgraded to Sell Amid Mixed Technicals and Fair Valuation

2026-09-01 08:14:45

Unjha Formulations Ltd has seen its investment rating downgraded from Hold to Sell, reflecting a reassessment across key parameters including technical trends, valuation metrics, financial performance, and overall quality. Despite recent price gains and market-beating returns, the company’s micro-cap status and flat quarterly results have weighed on its outlook, prompting a cautious stance from analysts.

Read full news article

Unjha Formulations Ltd: Valuation Shift Signals Caution Amid Strong Returns

2026-09-01 08:00:41

Unjha Formulations Ltd has experienced a notable shift in its valuation parameters, moving from an attractive to a fair valuation grade amid evolving market dynamics. This change reflects a recalibration of investor sentiment, driven by adjustments in key metrics such as the price-to-earnings (P/E) and price-to-book value (P/BV) ratios, when compared to both historical levels and peer benchmarks within the Pharmaceuticals & Biotechnology sector.

Read full news article

Unjha Formulations Ltd Upgraded to Hold on Technical and Valuation Improvements

2026-08-31 08:03:21

Unjha Formulations Ltd has seen its investment rating upgraded from Sell to Hold, reflecting a notable improvement in its technical indicators and valuation metrics despite flat recent financial performance. The upgrade, effective from 28 August 2026, is driven primarily by bullish technical trends, attractive valuation relative to peers, and a stable financial outlook, positioning the micro-cap pharmaceutical company for cautious optimism among investors.